Ítem
Solo Metadatos

Potential negative effects of the free use of chloroquine to manage COVID-19 in Colombia.

Mostrar el registro sencillo de la publicación
dc.creatorTeheran, Anibal Aspa
dc.creatorCamero, Gabrielspa
dc.creatorHernandez, Carolinaspa
dc.creatorPerez-Garcia, Luisspa
dc.creatorGuzman, Renatospa
dc.creatorPaniz-Mondolfi, Albertospa
dc.creatorRamírez, Juan David
dc.date.accessioned2020-06-11T13:21:54Z
dc.date.available2020-06-11T13:21:54Z
dc.date.created2020spa
dc.description.abstractCoronavirus disease 2019 (COVID-19) pandemic has challenged healthcare systems around the world. Unfortunately, failure has ensued: high-income countries have succumbed to the global emergency despite highly prepared human and technological assets. There is no current consensus on pharmacological management of COVID-19, but chloroquine phosphate (CQ) has emerged as a possible therapeutical candidate. However, no conclusive evidence has been published on the efficacy of CQ against SARS-CoV-2 infection. The Colombian government has approved the use of CQ for COVID-19, a measure that could negatively impact a large number of patients who depend on this drug for the treatment of other life-threatening diseases such as malaria and rheumatic autoimmune diseases. Careful consideration should be taken by Colombian authorities regarding the use of CQ in context of the ongoing pandemic. This article is protected by copyright. All rights reserved.eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1002/jmv.26059
dc.identifier.issn1096-9071
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/24949
dc.language.isoeng
dc.publisherJohn Wiley & Sons Inc.spa
dc.relation.citationTitleJournal of medical virology
dc.relation.ispartofJournal of medical virology, ISSN:1096-9071 (2020); pp. -spa
dc.rights.accesRightsinfo:eu-repo/semantics/closedAccess
dc.rights.accesoBloqueado (Texto referencial)spa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subject.keywordchloroquinespa
dc.subject.keywordcolombiaspa
dc.subject.keywordcoronavirusspa
dc.subject.keywordcovid-19spa
dc.subject.keywordeffectspa
dc.subject.keywordmalariaspa
dc.subject.keywordnegativespa
dc.subject.keywordpandemicspa
dc.subject.keywordrheumaticspa
dc.titlePotential negative effects of the free use of chloroquine to manage COVID-19 in Colombia.spa
dc.typearticleeng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaArtículospa
Archivos
Colecciones
Artículos